Infective endocarditis in adults.

By E. Mylonakis, S. Calderwood. New England Journal of Medicine, 2001

1,332 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Epidemiology, Public Health, Environmental and Occupational Health

View Paper: https://www.semanticscholar.org/paper/319ff03fa5679131c85b4e2246a5234ff73e7a24

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Rick A. Nishimura
2. Jose Luis Zamorano

Citations in the corpus

• Prevention of Infective Endocarditis (2007, neutral): “In developed countries, the frequency of RHD has declined, and MVP is now the most common underlying condition in patients with endocarditis.(104) Few published data quantitate the lifetime risk of acquisition of IE associated with a specific underlying cardiac condition.”
• ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (2006, background): “Endocarditis of the aortic and mitral valves has been associated with rapid death owing to acute valvular disruption, emboli to the coronary arteries, or abscesses in the valvular rings or the septum (492,493).”
• Guidelines for the Primary Prevention of Stroke (2011, neutral): “About 20% to 40% of patients with endocarditis suffer embolic events, the majority of which affect the central nervous system.(474,475) The rate of embolic events decreases rapidly after the initiation of antibiotic therapy.”
• GUIDELINES ON THE PREVENTION, DIAGNOSIS, AND TREATMENT OF INFECTIVE ENDOCARDITIS (NEW VERSION 2009) (2010, neutral): “2% per patientyear.(1,3,106,188,253,280) –284 It accounts for 10–30% of all cases of IE(280) and affects mechanical and bioprosthetic valves equally.”
• Risk of Embolism and Death in Infective Endocarditis: Prognostic Value of Echocardiography: A Prospective Multicenter Study (2005, neutral): “Coagulase-negative staphylococci 17 (4) 4 (3) 13 (5) 0.”
• Contemporary clinical profile and outcome of prosthetic valve endocarditis. (2007, neutral): “Duration of hospitalization, mean (range), d 33 (19-49) 29 (16-44) .”